PT1539124T - Composições e kits para a remoção de compostos irritantes de superfícies corporais - Google Patents

Composições e kits para a remoção de compostos irritantes de superfícies corporais

Info

Publication number
PT1539124T
PT1539124T PT03752011T PT03752011T PT1539124T PT 1539124 T PT1539124 T PT 1539124T PT 03752011 T PT03752011 T PT 03752011T PT 03752011 T PT03752011 T PT 03752011T PT 1539124 T PT1539124 T PT 1539124T
Authority
PT
Portugal
Prior art keywords
kits
compositions
removal
bodily surfaces
irritating compounds
Prior art date
Application number
PT03752011T
Other languages
English (en)
Inventor
C Jamieson Gene
Wilcox Allan
Roger Bley Keith
Angel Arturo
Litle Larry
Muhammad Naweed
Original Assignee
Vanderbilt Royalty Sub L P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vanderbilt Royalty Sub L P filed Critical Vanderbilt Royalty Sub L P
Publication of PT1539124T publication Critical patent/PT1539124T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Paints Or Removers (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PT03752011T 2002-09-05 2003-09-05 Composições e kits para a remoção de compostos irritantes de superfícies corporais PT1539124T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40875102P 2002-09-05 2002-09-05
US41061602P 2002-09-13 2002-09-13

Publications (1)

Publication Number Publication Date
PT1539124T true PT1539124T (pt) 2018-10-22

Family

ID=31981609

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03752011T PT1539124T (pt) 2002-09-05 2003-09-05 Composições e kits para a remoção de compostos irritantes de superfícies corporais

Country Status (15)

Country Link
US (10) US20040126430A1 (pt)
EP (1) EP1539124B1 (pt)
JP (2) JP4279254B2 (pt)
AU (1) AU2003270325A1 (pt)
CA (2) CA2903031C (pt)
CY (1) CY1120926T1 (pt)
DK (1) DK1539124T3 (pt)
EA (1) EA012367B1 (pt)
ES (1) ES2687970T3 (pt)
HU (1) HUE042241T2 (pt)
LT (1) LT1539124T (pt)
MX (1) MXPA05002440A (pt)
PT (1) PT1539124T (pt)
SI (1) SI1539124T1 (pt)
WO (1) WO2004021990A2 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040126430A1 (en) 2002-09-05 2004-07-01 Angel Arturo J. Compositions and kits for the removal of irritating compounds from bodily surfaces
WO2004045572A1 (en) * 2002-11-21 2004-06-03 J.P.M.E.D. Ltd. Compositions for treating infected skin and mucous membrane comprising an anti-microbial agent and an essential oil
CA2510181C (en) * 2002-12-18 2011-03-08 Algorx Pharmaceuticals, Inc. Administration of capsaicinoids
AU2003301190A1 (en) * 2002-12-18 2004-07-14 Algorx Administration of capsaicinoids
NZ542887A (en) * 2003-04-08 2008-05-30 Algorx Pharmaceuticals Inc Preparation and purification of synthetic capsaicin
EP2907503A1 (en) 2003-04-10 2015-08-19 Neurogesx, Inc. Methods and compositions for administration of TRPV1 agonists
DE102004009904A1 (de) * 2004-02-26 2005-09-22 Grünenthal GmbH Kit aus einem gegebenenfalls wirkstoffhaltigen Pflaster und einem Hautirritationen verhindernden Mittel
JP2006151971A (ja) * 2004-11-05 2006-06-15 Maruishi Pharmaceutical Co Ltd インスリン様成長因子−１分泌促進剤
KR20060040550A (ko) * 2004-11-05 2006-05-10 마루이시세이야쿠가부시키가이샤 인슐린유사 성장인자-1 분비촉진제
EP1827405A2 (en) * 2004-11-24 2007-09-05 Algorx Pharmaceuticals, Inc. Capsaicinoid gel formulation and uses thereof
US20070053965A1 (en) * 2005-02-25 2007-03-08 Gruenenthal Gmbh Kit comprising a plaster, optionally containing an active substance, and an agent that at least partially reduces skin irritation
PT1865941E (pt) * 2005-04-01 2011-01-05 Neurogesx Inc Óleos de capsaicinóides e métodos para a sua produção e utilização
US8057830B2 (en) * 2006-03-21 2011-11-15 Access Business Group International Llc Cleansing compositions and methods of reducing skin irritation
US7282224B1 (en) 2006-06-09 2007-10-16 Guthy-Renker Corporation Pain relief composition
US20080107747A1 (en) * 2006-10-23 2008-05-08 Roederer Joy E Pain relief composition
WO2008075615A1 (en) * 2006-12-21 2008-06-26 Semiconductor Energy Laboratory Co., Ltd. Light-emitting element and light-emitting device
AU2007347423B2 (en) 2007-02-23 2011-12-22 Hill's Pet Nutrition, Inc. Compositions and methods for preventing or treating obesity in animals
AU2008260774B2 (en) * 2007-06-08 2011-01-06 Samyang Biopharmaceuticals Corporation Matrix-type transdermal drug delivery system and preparation method thereof
US8158682B2 (en) * 2008-09-12 2012-04-17 Vallinex, Inc. Instillation administration of capsaicinoids for the treatment of pain
RU2010108361A (ru) * 2010-03-09 2011-09-20 Гаврилова Эмилия Евгеньевна (RU) Набор лечебных средств
KR101857827B1 (ko) * 2010-06-09 2018-05-14 카오카부시키가이샤 수증기 발생 온열구
JP2018501194A (ja) * 2014-10-31 2018-01-18 アヴェント インコーポレイテッド 膀胱収縮の抑制に関連する用途のための方法および装置
CN108473484B (zh) 2015-10-01 2021-06-29 弗门尼舍公司 可用作trpm8调节剂的化合物
JP7412870B2 (ja) * 2017-06-27 2024-01-15 小林製薬株式会社 外用組成物
JP7412871B2 (ja) * 2017-06-27 2024-01-15 小林製薬株式会社 外用組成物
EA031658B1 (ru) * 2017-06-30 2019-02-28 Акционерное Общество "Верофарм" Антицеллюлитный косметический комплекс
CA3030489A1 (en) * 2018-01-19 2019-07-19 Kwang Hyun Park Composition for controlling secretion of prostasomes and use thereof

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4239781A (en) * 1979-05-03 1980-12-16 Roy Edwards Method for treating skin ailments
US4303066A (en) * 1979-06-28 1981-12-01 National Patent Development Corporation Burn dressing
US4387107A (en) * 1979-07-25 1983-06-07 Dermik Laboratories, Inc. Stable benzoyl peroxide composition
GB2075837B (en) * 1980-05-14 1984-03-14 Hisamitsu Pharmaceutical Co Topical pharmaceutical gel containing anti-inflammatory analgesic agents
US4424205A (en) * 1982-03-18 1984-01-03 The Procter & Gamble Company Hydroxyphenylacetamides having analgesic and anti-irritant activity
US4493848A (en) * 1983-07-14 1985-01-15 The Procter & Gamble Company Compositions and methods useful for producing analgesia
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
GB8401206D0 (en) * 1984-01-17 1984-02-22 Allied Colloids Ltd Polymers and aqueous solutions
GB8414950D0 (en) * 1984-06-12 1984-07-18 Allied Colloids Ltd Cationic polyelectrolytes
CA1263606A (en) * 1985-05-29 1989-12-05 Jeffrey P. Gilbard Non-toxic opthalmic preparations
GB8531118D0 (en) 1985-12-18 1986-01-29 Allied Colloids Ltd Copolymers
GB8622797D0 (en) * 1986-09-22 1986-10-29 Allied Colloids Ltd Polymeric particles
US4835206A (en) * 1986-10-01 1989-05-30 Allied Colloids, Ltd. Water soluble polymeric compositions
US5202118A (en) * 1987-12-18 1993-04-13 Immunex Corporation Method for promoting wound healing using IL-1
US4939149A (en) * 1988-10-24 1990-07-03 The United States Of America As Represented By The Department Of Health And Human Services Resiniferatoxin and analogues thereof to cause sensory afferent C-fiber and thermoregulatory desensitization
GB8909095D0 (en) * 1989-04-21 1989-06-07 Allied Colloids Ltd Thickened aqueous compositions
CA2063576C (en) * 1989-06-07 1994-01-25 Gail S. Bazzano Slow release vehicles for minimizing skin irritancy of topical compositions
US5633285A (en) * 1991-03-01 1997-05-27 Warner-Lambert Company Cytoprotective wound healing compositions and methods for preparing and using same
ES2076784T3 (es) * 1991-10-07 1995-11-01 Nephin Barra solida para el aseo.
ATE156997T1 (de) * 1992-06-17 1997-09-15 Procter & Gamble Nichtstechende zusammensetzungen mit kühleffekt
US5288814A (en) * 1992-08-26 1994-02-22 The B. F. Goodrich Company Easy to disperse polycarboxylic acid thickeners
US5376732A (en) * 1992-10-30 1994-12-27 Research Corporation Technologies, Inc. Polymers having oxidic functionality and derivatives thereof
US5910512A (en) * 1994-04-18 1999-06-08 Healthline Laboratories, Inc. Topical analgesic using water soluble capsaicin
FR2721213B1 (fr) 1994-06-15 1996-09-13 Pf Medicament Procédé de préparation d'un extrait de Capsicum, riche en capsaïcine et autres capsinoïdes.
US5624906A (en) * 1994-12-08 1997-04-29 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions comprising heteroatom containing alkyl aldonamide compounds
WO1996037591A1 (en) * 1995-05-27 1996-11-28 The Procter & Gamble Company Cleansing compositions
US5703026A (en) * 1995-06-01 1997-12-30 The Procter & Gamble Company Skin cleansing bar soap compositions comprising particles of absorbent gellant materials
US5747052A (en) * 1995-06-09 1998-05-05 Anthony Rizzo Aqueous composition to neutralize the irritating effect of capsaicin on eyes, skin and mucous membranes
US6239180B1 (en) 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
US6248788B1 (en) 1996-11-06 2001-06-19 The Regents Of The University Of California Therapeutic method with capsaicin and capasicin analogs
US5958436A (en) * 1995-12-21 1999-09-28 Cosmederm Technologies Formulations and methods for reducing skin irritation
US5698191A (en) * 1996-01-30 1997-12-16 Nouveau Technologies, Inc. Non-lethal bio-repellent compositions
US5856361A (en) * 1996-04-23 1999-01-05 Medical Merchandising, Inc. Pain reliever and method of use
EP1201241B8 (en) * 1997-03-13 2010-10-27 James N. Campbell Compositions containing capsaicin or capsaicin analogues and an anesthetic
US5922331A (en) * 1997-03-26 1999-07-13 Chanel, Inc. Skin cream composition
US5827886A (en) * 1997-05-07 1998-10-27 Thione International, Inc. Composition for relief of arthritis-induced symptoms
AU8438798A (en) * 1997-06-16 1999-01-04 Janssen Pharmaceutica N.V. Use of draflazine-analogues for treating pain
TW460293B (en) * 1997-10-28 2001-10-21 Kao Corp External skin-care composition
EP0916334A1 (en) 1997-11-07 1999-05-19 Unilever Plc Detergent composition
US6113892A (en) * 1997-12-23 2000-09-05 Helene Curtis, Inc. Compositions for cleansing, conditioning and moisturizing hair and skin
US6015763A (en) * 1998-02-17 2000-01-18 Dotolo Research Corp. Cleaner impregnated towel
US6013270A (en) * 1998-04-20 2000-01-11 The Procter & Gamble Company Skin care kit
JP3211027B2 (ja) * 1998-11-13 2001-09-25 丸石製薬株式会社 カプサイシン含有外用剤
US6390291B1 (en) * 1998-12-18 2002-05-21 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
JP2000191510A (ja) 1998-12-28 2000-07-11 Kao Corp 皮膚洗浄剤組成物
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US5994407A (en) * 1999-06-16 1999-11-30 Cuilty-Siller; Carlos Procedure to prepare a solution with capsaicin
US7074747B1 (en) * 1999-07-01 2006-07-11 Johnson & Johnson Consumer Companies, Inc. Cleansing compositions
WO2001001949A1 (en) * 1999-07-01 2001-01-11 Johnson And Johnson Consumer Companies, Inc. Cleansing compositions
HU225734B1 (en) * 1999-07-28 2007-07-30 Zoltan Dardai Multilayer plaster for introducing peptidaceous pharmacons in living organisms and process for producing thereof
DE10009252A1 (de) * 2000-03-01 2001-09-06 Henkel Kgaa Wärmendes Hautreinigungsgel
US6342470B1 (en) * 2000-04-26 2002-01-29 Unilever Home & Personal Care Usa Bar comprising soap, fatty acid, polyalkylene glycol and protic acid salts in critical ratios and providing enhanced skin care benefits
US6774100B2 (en) * 2000-12-06 2004-08-10 Imaginative Research Associates, Inc. Anhydrous creams, lotions and gels
US20030235549A1 (en) * 2001-05-01 2003-12-25 Parminder Singh Hydrogel compositions demonstrating phase separation on contact with aqueous media
US6465022B1 (en) 2001-06-19 2002-10-15 New Mexico Tech Research Foundation Method of providing an essential oil extract of capsicum, and the extract
US6428772B1 (en) * 2001-06-25 2002-08-06 Blistex Inc. Acne treatment composition with cooling effect
JP3881871B2 (ja) * 2001-11-13 2007-02-14 三菱重工業株式会社 ガスタービンの燃料制御方法、及びそれに供する制御装置
US20040126430A1 (en) 2002-09-05 2004-07-01 Angel Arturo J. Compositions and kits for the removal of irritating compounds from bodily surfaces
US20040131560A1 (en) * 2002-10-04 2004-07-08 The Procter & Gamble Company Oral compositions and use thereof
WO2005027642A1 (en) 2003-09-25 2005-03-31 Darren Wayne Eade Repellent preparations
US20060018845A1 (en) * 2004-07-23 2006-01-26 Edelstein Janette S Tooth whitening
DE102011077796A1 (de) 2011-06-20 2012-12-20 Voith Patent Gmbh Verfahren und System zur Wärmerückgewinnung für eine Trockenpartie einer Maschine zur Herstellung einer Materialbahn

Also Published As

Publication number Publication date
ES2687970T3 (es) 2018-10-30
CA2497771C (en) 2015-11-03
LT1539124T (lt) 2018-11-12
HUE042241T2 (hu) 2019-06-28
SI1539124T1 (sl) 2018-12-31
EP1539124A4 (en) 2011-02-23
US20040126430A1 (en) 2004-07-01
CA2903031A1 (en) 2004-03-18
JP2006502166A (ja) 2006-01-19
US8889113B2 (en) 2014-11-18
WO2004021990A3 (en) 2004-08-26
US10463598B2 (en) 2019-11-05
US20060204564A1 (en) 2006-09-14
EA012367B1 (ru) 2009-10-30
US10869827B2 (en) 2020-12-22
US11534388B2 (en) 2022-12-27
US20150104498A1 (en) 2015-04-16
US20210205205A1 (en) 2021-07-08
US20170312214A1 (en) 2017-11-02
JP2009084289A (ja) 2009-04-23
EP1539124B1 (en) 2018-07-18
CA2497771A1 (en) 2004-03-18
US20100269858A1 (en) 2010-10-28
EP1539124A2 (en) 2005-06-15
JP4279254B2 (ja) 2009-06-17
DK1539124T3 (en) 2018-10-08
EA200500442A1 (ru) 2005-10-27
US20200085718A1 (en) 2020-03-19
WO2004021990A2 (en) 2004-03-18
CA2903031C (en) 2019-04-16
US8263059B2 (en) 2012-09-11
CY1120926T1 (el) 2019-12-11
US20040180081A1 (en) 2004-09-16
US20060204563A1 (en) 2006-09-14
US20120323258A1 (en) 2012-12-20
AU2003270325A8 (en) 2004-03-29
US9549893B2 (en) 2017-01-24
MXPA05002440A (es) 2005-11-17
AU2003270325A1 (en) 2004-03-29

Similar Documents

Publication Publication Date Title
AU2003270325A8 (en) Compositions and kits for the removal of irritating compounds from bodily surfaces
EP1628530B8 (en) Methods and compositions for the prevention and treatment of sepsis
EP1576150A3 (en) Methods and compositions for increasing the efficacy of biologically-active ingredients
ZA200501913B (en) New compounds for the inhibition of rotamases and use thereof
AU2003255482A1 (en) Use of 4 amino-quinazolines as anti cancer agents
PL1894564T3 (pl) Zastosowanie inhibitora IBAT do leczenia lub profilaktyki zaparcia
AU2003213787A1 (en) Compositions and methods for the treatment of anorectal disorders
AU2003290605A1 (en) Compositions and methods for the diagnosis and treatment of sepsis
AU2003291443A1 (en) Compositions and processes for nanoimprinting
IL165839A0 (en) Compounds useful for the treatment of cancer compositions thereof and methods therewith
AU2003222352A1 (en) Compositions for the treatment of magnesium alloys
AU2003220343A1 (en) Compositions of pentafluoropropane
AU2002249983A1 (en) Compositions and methods for diagnosis of neuropsychiatric disorders
AU2003220026A1 (en) Methods and compositions for the treatment of ischemia
AU2003270683A1 (en) Compounds for the treatment of premature ejaculation
AU2003251362A1 (en) Compositions formed from the reduction of lanolin
AU2003240174A1 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
GB0313630D0 (en) Compositions for the enhanced treatment of depression
AU2004311370A1 (en) Methods and compositions for the inhibition of cathepsins
AU2003285261A1 (en) Compositions for the treatment of mycobacterial infections
AU2001257164A1 (en) Methods and compositions for the diagnosis of schizophrenia
AU2001257179A1 (en) Methods and compositions for the diagnosis of schizophrenia
AU2001257180A1 (en) Methods and compositions for the diagnosis of schizophrenia
AU2001255606A1 (en) Methods and compositions for the diagnosis of schizophrenia
AU2001255597A1 (en) Methods and compositions for the diagnosis of schizophrenia